4//SEC Filing
Davarpanah Nicole Negar 4
Accession 0001610618-25-000086
CIK 0001610618other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 7:05 PM ET
Size
5.8 KB
Accession
0001610618-25-000086
Insider Transaction Report
Form 4
Davarpanah Nicole Negar
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-09-11$62.86/sh−474$29,797→ 31,418 total
Footnotes (3)
- [F1]The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.86 to $63.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2025.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0002067554
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 7:05 PM ET
- Size
- 5.8 KB